Pulmonary Emphysema Clinical Trial
Official title:
Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE)
The purpose of this study is to demonstrate the safety and efficacy of AeriSeal System treatment plus optimal medical therapy compared in patients with advanced upper lobe predominant (ULP) heterogeneous emphysema.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT00995852 -
Unilateral Versus Bilateral Endoscopic Lung Volume Reduction A Comparative Case Study
|
Phase 2/Phase 3 | |
Completed |
NCT01860898 -
A Phase I Study of iPS Cell Generation From Patients With COPD
|
N/A | |
Completed |
NCT00123422 -
Innovation in Pulmonary Rehabilitation
|
N/A | |
Recruiting |
NCT02879331 -
Clinical Study to Evaluate the Exercise Capacity in Patients With Severe Emphysema Treated With Coils
|
N/A | |
Completed |
NCT01507415 -
Do the SPPB and 4-metre Gait Speed Predict Hospital Readmission in Patients Hospitalised for Acute Exacerbation if COPD?
|
N/A | |
Completed |
NCT01051258 -
AeriSeal System for Lung Volume Reduction
|
Phase 1/Phase 2 | |
Completed |
NCT00680056 -
Add-on Effects of Tiotropium Over Formoterol in Exercise Tolerance on Chronic Obstructive Pulmonary Disease Patients
|
Phase 4 | |
Completed |
NCT01872624 -
Safety Study of Bone-marrow Derived Mesenchymal Stromal Cells Associated With Endobronchial Valves in Emphysema
|
N/A | |
Completed |
NCT01110252 -
Safety Study of Cell Therapy to Treat Chronic Obstructive Pulmonary Disease
|
N/A | |
Completed |
NCT00517998 -
Israeli Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study
|
Phase 1 | |
Terminated |
NCT00205920 -
Netherlands 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation
|
Phase 2 | |
Withdrawn |
NCT01849159 -
Clinical Study of the Efficacy and Safety of the Application of Allogeneic Mesenchymal (Stromal) Cells of Bone Marrow, Cultured Under the Hypoxia in the Treatment of Patients With Severe Pulmonary Emphysema
|
Phase 1/Phase 2 | |
Completed |
NCT01869205 -
The Effect and Mechanism of Bronchoscopic Lung Volume Reduction by Endobronchial Valve in Korean Emphysema Patients
|
Phase 3 | |
Terminated |
NCT01320566 -
A Continuation Study of the AeriSeal® System Administered at 3 to 4 Sites During a Single Treatment Session for Lung Volume Reduction in Patients With Advanced Emphysema
|
Phase 2/Phase 3 | |
Completed |
NCT00683722 -
PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2 | |
Active, not recruiting |
NCT04465461 -
Video Assisted Thoracic Surgery (VATS) Fissure Completion Prior to Zephyr® Endobronchial Valve Insertion
|
N/A | |
Completed |
NCT04012359 -
Description of Bullous Emphysema Using Lung Ultrasound and Comparison to the Characteristics of Pneumothorax
|
||
Recruiting |
NCT04918706 -
Allogeneic MSC Treatment for Pulmonary Emphysema
|
Phase 2 | |
Completed |
NCT00347659 -
US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study
|
Phase 1 | |
Recruiting |
NCT02827721 -
Evaluation of Novel Lung Function Parameters in Patients With Chronic Obstructive Pulmonary Disease (COPD)
|